FDA Inspection 832454 — Leo Pharma Inc
The FDA completed an inspection of Leo Pharma Inc on May 20, 2013 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 20, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Parsippany, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)